News
Quite a few insiders have dramatically grown their holdings in OptimizeRx Corporation ( NASDAQ:OPRX ) over the past ...
It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns ...
6dOpinion
Zacks Investment Research on MSNBest Growth Stocks to Buy for July 22nd
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today July 22nd: OptimizeRx ...
Last time around, it was the Federal Reserve's aggressive interest-rate hikes that finally put an end to the stock market's party in early 2022. This time, higher borrowing costs haven't done much to ...
OptimizeRx is poised for profitability by 2025 with AI-driven healthcare marketing, innovative platforms, and strong growth ...
3d
Zacks.com on MSNOPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
Detailed price information for Healthstream Inc (HSTM-Q) from The Globe and Mail including charting and trades.
10d
Zacks.com on MSNCan OPRX's Patient Engagement Tools Win Amid Fierce Competition?
Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.
OptimizeRx is navigating macro uncertainty with agility, benefiting from a growing base of committed revenues, cost efficiencies and a pivot to subscriptions. Continued execution in monetizing data ...
OptimizeRx OPRX kicked off 2025 with strong momentum, delivering 11% year-over-year revenue growth to $21.9 million and turning in $1.5 million in adjusted EBITDA, its strongest first-quarter ...
High Court allows CBI to investigate fund diversion cases involving Karnataka Maharshi Valmiki Scheduled Tribes Development Corporation Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results